Molecular Imaging of RNA Interference Therapy Targeting PHD2 for Treatment of Myocardial Ischemia

Methods in Molecular Biology

Volumn 709, Issue , 2011, Pages 211-221

  Huang, Mei ^a   Wu, Joseph C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hypoxia inducible factor (HIF); Ischemic heart disease; Molecular imaging; Prolyl hydroxylases (PHD); RNA interference

Indexed keywords

EGLN1 PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LUCIFERASE; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; SMALL INTERFERING RNA;

ANIMAL; ARTICLE; CELL CULTURE; GENE EXPRESSION; GENETICS; HEART MUSCLE ISCHEMIA; HUMAN; METABOLISM; MOLECULAR IMAGING; MOUSE; PROMOTER REGION; REPORTER GENE; RNA INTERFERENCE;

ANIMALS; CELLS, CULTURED; GENE EXPRESSION; GENES, REPORTER; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LUCIFERASES; MICE; MOLECULAR IMAGING; MYOCARDIAL ISCHEMIA; PROCOLLAGEN-PROLINE DIOXYGENASE; PROMOTER REGIONS, GENETIC; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 79960060795     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61737-982-6_13     Document Type: Chapter

References (21)

1. Rosamond, W., Flegal, K., Friday, G., Furie, K., Go, A., Greenlund, K., Haase, N., Ho, M., Howard, V., Kissela, B., Kittner, S., Lloyd-Jones, D., McDermott, M., Meigs, J., Moy, C., Nichol, G., O’Donnell, C. J., Roger, V., Rumsfeld, J., Sorlie, P., Steinberger, J., Thom, T., Wasserthiel-Smoller, S. and Hong, Y. (2007) Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 115, e69–e171.
2. Kim, M. C., Kini, A. and Sharma, S. K. (2002) Refractory angina pectoris: mechanism and therapeutic options. J Am Coll Cardiol 39, 923–934.
3. Nabel, G. J. (2004) Genetic, cellular and immune approaches to disease therapy: past and future. Nat Med 10, 135–141.
4. Yla-Herttuala, S. and Alitalo, K. (2003) Gene transfer as a tool to induce therapeutic vascular growth. Nat Med 9, 694–701.
5. Isner, J. M. (2002) Myocardial gene therapy. Nature 415, 234–239.
6. Luttun, A., Tjwa, M., Moons, L., Wu, Y., Angelillo-Scherrer, A., Liao, F., Nagy, J. A., Hooper, A., Priller, J., De Klerck, B., Compernolle, V., Daci, E., Bohlen, P., Dewerchin, M., Herbert, J. M., Fava, R., Matthys, P., Carmeliet, G., Collen, D., Dvorak, H. F., Hicklin, D. J. and Carmeliet, P. (2002) Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med 8, 831–840.
7. Vincent, K. A., Feron, O. and Kelly, R. A. (2002) Harnessing the response to tissue hypoxia: HIF-1 alpha and therapeutic angiogenesis. Trends Cardiovasc Med 12, 362–367.
8. Fukuda, R., Hirota, K., Fan, F., Jung, Y. D., Ellis, L. M. and Semenza, G. L. (2002) Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphati-dylinositol 3-kinase signaling in colon cancer cells. J Biol Chem 277, 38205–38211.
9. Stolze, I., Berchner-Pfannschmidt, U., Freitag, P., Wotzlaw, C., Rossler, J., Frede, S., Acker, H. and Fandrey, J. (2002) Hypoxia-inducible erythropoietin gene expression in human neuroblastoma cells. Blood 100, 2623–2628.
10. Sandau, K. B., Fandrey, J. and Brune, B. (2001) Accumulation of HIF-1alpha under the influence of nitric oxide. Blood 97, 1009–1015.
11. Jewell, U. R., Kvietikova, I., Scheid, A., Bauer, C., Wenger, R. H. and Gassmann, M. (2001) Induction of HIF-1alpha in response to hypoxia is instantaneous. FASEB J 15, 1312–1314.
12. Chan, D. A., Sutphin, P. D., Denko, N. C. and Giaccia, A. J. (2002) Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1alpha. J Biol Chem 277, 40112–40117.
13. 2 sensing. Science 292, 464–468.
14. 2 tension. Am J Physiol 271, C1172–C1180.
15. Pislaru, S., Janssens, S. P., Gersh, B. J. and Simari, R. D. (2002) Defining gene transfer before expecting gene therapy: putting the horse before the cart. Circulation 106, 631–636.
16. Yla-Herttuala, S., Markkanen, J. E. and Rissanen, T. T. (2004) Gene therapy for ischemic cardiovascular diseases: some lessons learned from the first clinical trials. Trends Cardiovasc Med 14, 295–300.
17. Wu, J. C. and Yla-Herttuala, S. (2005) Human gene therapy and imaging: cardiology. Eur J Nucl Med Mol Imaging 32 Suppl 2, S346–S357.
18. Huang, M., Chan, D. A., Jia, F., Xie, X., Li, Z., Hoyt, G., Robbins, R. C., Chen, X., Giaccia, A. J. and Wu, J. C. (2008) Short hairpin RNA interference therapy for ischemic heart disease. Circulation 118, S226–S233.
19. Miyagishi, M. and Taira, K. (2002) U6 pro-moter-driven siRNAs with four uridine 3¢ overhangs efficiently suppress targeted gene expression in mammalian cells. Nat Biotechnol 20, 497–500.
20. Ruan, H., Su, H., Hu, L., Lamborn, K. R., Kan, Y. W. and Deen, D. F. (2001) A hypoxia-regu-lated adeno-associated virus vector for cancer-specific gene therapy. Neoplasia 3, 255–263.
21. Cao, F., Lin, S., Xie, X., Ray, P., Patel, M., Zhang, X., Drukker, M., Dylla, S. J., Connolly, A. J., Chen, X., Weissman, I. L., Gambhir, S. S. and Wu, J. C. (2006) In vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery. Circulation 113, 1005–1014.